CBD (Cannabidiol) studies around the world part 1


Cannabidiol (or its more common name 'CBD') has been attracting a great deal of attention recently.

CBD has shown nutritional potential for years, yet the taboo surrounding Cannabis has kept CBD well off the radar.

Now, that hemp has gained the reputation it deserves, it looks as though this little compound is finally poised for big market growth.

Let's look into the latest CBD research! 

Cannabidiol Anxiety Research

There have been many studies revering CBD to be an effective solution to anxiety , other studies promote its anti inflammatory qualities and there is even further studies proclaiming the potential for CBD as a powerful solution to epilepsy.

However, despite the early stage of many studies (some which are still very much at the pre-clinical stage), many doctors and medical organizations are already endorsing Cannabidiol as a low-risk treatment for anxiety, as well as exploring the possibilities of using CBD for more severe mood disorders closely related to anxiety, such as depression. 

Cannabidiol Antipsychotic Research

A preliminary clinical trial at the University of California–Irvine has concluded that CBD seems to treat schizophrenia as effectively as current antipsychotic medications, with far fewer side effects and at a lesser cost. Daniele Piomelli, a professor of pharmacology at the university and co-author of the study said, “The results were amazing, not only was [CBD] as effective as standard antipsychotics, but it was also essentially free of the typical side effects seen with antipsychotic drugs.”

Common side effects of antipsychotic drugs include social withdrawal, lack of motivation, and anxiety, all of which frequently occur in schizophrenia as well. Therefore, since those drugs can themselves cause some of schizophrenia’s symptoms, it is still unclear whether CBD is better at treating them or whether it is simply causing fewer of these side effects in the first place. This is the focus of many current studies on CBD’s properties.

Perhaps most interesting of all is the fact that CBD seems to counteract the psychotropic effects of THC, which has been shown to have strong correlation with psychosis when used long-term. Using CBD alongside THC seems to drastically lower the potential of the latter to cause psychosis, a fact that has taken many scientific teams by surprise.

Cannabidiol Arthritis Research 

Studies conducted in lab rats have shown that CBD drastically reduces a model of acute arthritis that applies to numerous different types of joint disorders. While these studies imply that CBD may only indirectly affect arthritis, the findings themselves are encouraging. Nonetheless, the exact mechanisms with which Cannabidiol interacts with arthritis are still not fully understood.

One other indirect benefit that CBD seems to have when administered for arthritis is that it has been shown to reduce the pain caused by several types of arthritis, including the prevalent rheumatoid arthritis. Still, it is not yet clear whether CBD’s anti-inflammatory properties or its analgesic effects play the biggest part in alleviating arthritis-induced pain. Some studies point toward both and if that is eventually proven, it may render CBD a widely accepted treatment for both arthritis and a host of arthritis-related pains.

Previous Post Next Post

  • John Yoda
Comments 0
Leave a comment
Your Name:*
Email Address:*
Message: *

Please note: comments must be approved before they are published.

* Required Fields